These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21426158)
1. Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency. Thompson RL; Sawtell NM Future Med Chem; 2010 Jul; 2(7):1099-105. PubMed ID: 21426158 [TBL] [Abstract][Full Text] [Related]
2. Can HSV latency be conquered by current antiviral therapies? Simmons A; Field HJ Sex Transm Infect; 1998 Feb; 74(1):1-2. PubMed ID: 9634293 [No Abstract] [Full Text] [Related]
3. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis]. Shimomura Y Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713 [TBL] [Abstract][Full Text] [Related]
4. Antagonizing the Glucocorticoid Receptor Impairs Explant-Induced Reactivation in Mice Latently Infected with Herpes Simplex Virus 1. Harrison KS; Zhu L; Thunuguntla P; Jones C J Virol; 2019 Jul; 93(13):. PubMed ID: 30971470 [TBL] [Abstract][Full Text] [Related]
5. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Halford WP; Weisend C; Grace J; Soboleski M; Carr DJ; Balliet JW; Imai Y; Margolis TP; Gebhardt BM Virol J; 2006 Jun; 3():44. PubMed ID: 16764725 [TBL] [Abstract][Full Text] [Related]
6. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. Thompson RL; Preston CM; Sawtell NM PLoS Pathog; 2009 Mar; 5(3):e1000352. PubMed ID: 19325890 [TBL] [Abstract][Full Text] [Related]